{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:32:12Z","timestamp":1793910732569,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In patients with colorectal cancer and peritoneal metastases (CRC-PM), the completeness of cytoreductive surgery (CRS) is crucial. However, a history of moderate (Prior Surgical Score, PSS-2) or extensive (PSS-3) abdominal surgery may compromise the exploration, increasing the risk of undetected CRC-PM. This retrospective monocentric study investigated the value of preoperative peritoneal magnetic resonance imaging (MRI) in identifying potentially occult lesions in patients with PSS-2\/3 CRC-PM scheduled for CRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Consecutive patients with pathologically confirmed CRC-PM and PSS-2\/3, selected for radical treatment, were included. All underwent preoperative peritoneal MRI \u2264 7 days before CRS, between January 2015 and December 2020. MRI, surgical, and pathological reports were reviewed focusing on seven anatomical sites of interest (perihepatic, pelvic, retroperitoneum, abdominal wall, anastomosis, inguinal canal, and cardiophrenic space).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 248 patients were included; 242 (97.6%) underwent complete CRS (CC-0). Among them, 212 (85.5%) were PSS-2 and 36 (14.5%) PSS-3. The sensitivity, specificity, and accuracy of MRI in detecting lesions were, respectively, 65%, 91%, and 82% (perihepatic region); 53%, 81%, and 63% (pelvis); 41%, 91%, and 69% (retroperitoneum); 46%, 91%, and 79% (abdominal wall); and 44%, 98%, and 74% (anastomotic sites). In the inguinal canal and cardiophrenic space, preoperative MRI led to ten resections in ten patients, with neoplastic cells detected in eight cases (80%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preoperative peritoneal MRI demonstrated good specificity and a promising negative predictive value (NPV) but modest sensitivity in detecting lesions across seven anatomically challenging regions. Further studies are warranted to better define its added value over standard preoperative imaging protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18022-0","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:59:01Z","timestamp":1754510341000},"page":"1673-1683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History"],"prefix":"10.1245","volume":"33","author":[{"given":"Boris","family":"Cleret de Langavant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaniel","family":"Kefleyesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Peron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Benzerdjeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"3","key":"18022_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"18022_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","volume":"47","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Bakkers C, Rijken A, et al. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol. 2021;47(5):1026\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.135.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"18022_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128(11):2717\u201325. https:\/\/doi.org\/10.1002\/ijc.25596.","journal-title":"Int J Cancer."},{"issue":"1","key":"18022_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7(1):91. https:\/\/doi.org\/10.1038\/s41572-021-00326-6.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"18022_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","volume":"19","author":"RC Dresen","year":"2019","unstructured":"Dresen RC, De Vuysere S, De Keyzer F, et al. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging. 2019;19(1):1. https:\/\/doi.org\/10.1186\/s40644-018-0187-z.","journal-title":"Cancer Imaging."},{"issue":"12","key":"18022_CR6","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319. https:\/\/doi.org\/10.1016\/S1470-2045(16)30500-9.","journal-title":"Lancet Oncol."},{"issue":"2","key":"18022_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejso.2021.09.014","volume":"48","author":"I Vant Sant","year":"2022","unstructured":"Vant Sant I, Nerad E, Rijsemus CJV, et al. Seeing the whole picture: added value of MRI for extraperitoneal findings in CRS-HIPEC candidates. Eur J Surg Oncol. 2022;48(2):462\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2021.09.014.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"18022_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"key":"18022_CR9","doi-asserted-by":"publisher","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","volume":"11","author":"O Kranenburg","year":"2021","unstructured":"Kranenburg O, Speeten KVD, Hingh ID. Peritoneal metastases from colorectal cancer: defining and addressing the challenges. Front Oncsol. 2021;11:650098. https:\/\/doi.org\/10.3389\/fonc.2021.650098.","journal-title":"Front Oncsol."},{"key":"18022_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2019-0022","author":"V Narasimhan","year":"2019","unstructured":"Narasimhan V, Warrier S, Michael M, et al. Perceptions in the management of colorectal peritoneal metastases: a bi-national survey of colorectal surgeons. Pleura and Peritoneum. 2019. https:\/\/doi.org\/10.1515\/pp-2019-0022.","journal-title":"Pleura and Peritoneum."},{"issue":"3","key":"18022_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61(3):347\u201354. https:\/\/doi.org\/10.1097\/DCR.0000000000001003.","journal-title":"Dis Colon Rectum."},{"issue":"1","key":"18022_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00261-007-9211-7","volume":"33","author":"C Dromain","year":"2008","unstructured":"Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs PET\/CT. Abdom Imaging. 2008;33(1):87\u201393. https:\/\/doi.org\/10.1007\/s00261-007-9211-7.","journal-title":"Abdom Imaging."},{"key":"18022_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5180895","volume":"2019","author":"FS Koumpa","year":"2019","unstructured":"Koumpa FS, Xylas D, Konopka M, et al. Colorectal peritoneal metastases: a systematic review of current and emerging trends in clinical and translational research. Gastroenterol Res Pract. 2019;2019:1\u201330. https:\/\/doi.org\/10.1155\/2019\/5180895.","journal-title":"Gastroenterol Res Pract."},{"issue":"1","key":"18022_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. European J Surg Oncol. 2021;47(1):11\u201335. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012.","journal-title":"European J Surg Oncol."},{"key":"18022_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10645-3","author":"D Caruso","year":"2024","unstructured":"Caruso D, Polici M, Bellini D, Laghi A. ESR Essentials: imaging in colorectal cancer\u2014practice recommendations by ESGAR. Eur Radiol. 2024. https:\/\/doi.org\/10.1007\/s00330-024-10645-3.","journal-title":"Eur Radiol."},{"issue":"4","key":"18022_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1148\/radiographics.12.4.1636042","volume":"12","author":"JE Barnes","year":"1992","unstructured":"Barnes JE. Characteristics and control of contrast in CT. RadioGraphics. 1992;12(4):825\u201337. https:\/\/doi.org\/10.1148\/radiographics.12.4.1636042.","journal-title":"RadioGraphics."},{"issue":"2","key":"18022_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16(2):327\u201333. https:\/\/doi.org\/10.1245\/s10434-008-0234-2.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"18022_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/bjs.10989","volume":"106","author":"I Vant Sant","year":"2019","unstructured":"Vant Sant I, van Eden WJ, Engbersen MP, et al. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery. Br J Surg. 2019;106(4):491\u20138. https:\/\/doi.org\/10.1002\/bjs.10989.","journal-title":"Br J Surg."},{"issue":"6","key":"18022_CR19","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","volume":"30","author":"I Vant Sant","year":"2020","unstructured":"Vant Sant I, Engbersen MP, Bhairosing PA, et al. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol. 2020;30(6):3101\u201312. https:\/\/doi.org\/10.1007\/s00330-019-06524-x.","journal-title":"Eur Radiol."},{"key":"18022_CR20","doi-asserted-by":"publisher","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Vol 82. Cancer Treat Res. Springer US; 1996:359-374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"6","key":"18022_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","volume":"42","author":"L Villeneuve","year":"2016","unstructured":"Villeneuve L, Thivolet A, Bakrin N, et al. A new internet tool to report peritoneal malignancy extent PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application. Eur J Surg Oncol. 2016;42(6):877\u201382. https:\/\/doi.org\/10.1016\/j.ejso.2016.03.015.","journal-title":"Eur J Surg Oncol."},{"key":"18022_CR22","unstructured":"Rousset P. Pictorial essays on peritoneal metastases imaging: CT, MRI and PET-CT. In: Pictorial Essays on Peritoneal Metastases Imaging: CT, MRI and PET-CT. Nova Science Publishers Inc. ; 2020:237."},{"issue":"1","key":"18022_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejso.2019.02.030","volume":"47","author":"RN Low","year":"2021","unstructured":"Low RN, Barone RM, Rousset P. Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation. Eur J Surg Oncol. 2021;47(1):65\u201374. https:\/\/doi.org\/10.1016\/j.ejso.2019.02.030.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"18022_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/SLAS00600043","volume":"6","author":"CE Scott-Conner","year":"1999","unstructured":"Scott-Conner CE, Hedican S. Laparoscopic anatomy of the pelvis. Semin Laparosc Surg. 1999;6(2):43\u201350. https:\/\/doi.org\/10.1053\/SLAS00600043.","journal-title":"Semin Laparosc Surg."},{"issue":"4","key":"18022_CR25","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1245\/s10434-023-14840-2","volume":"31","author":"R Grange","year":"2024","unstructured":"Grange R, Rousset P, Williet N, et al. Metastatic colorectal cancer treated with combined liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): predictive factors for early recurrence. Ann Surg Oncol. 2024;31(4):2378\u201390. https:\/\/doi.org\/10.1245\/s10434-023-14840-2.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18022_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg."},{"issue":"1","key":"18022_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41416-022-02037-5","volume":"128","author":"ME Kelly","year":"2023","unstructured":"Kelly ME, O\u2019Sullivan NJ, Bolger JC, et al. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry. Br J Cancer. 2023;128(1):42\u20137. https:\/\/doi.org\/10.1038\/s41416-022-02037-5.","journal-title":"Br J Cancer."},{"issue":"5","key":"18022_CR28","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00464-019-06984-8","volume":"34","author":"H Najah","year":"2020","unstructured":"Najah H, Malgras B, Dohan A, Gronnier C, Eveno C, Pocard M. The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases. Surg Endosc. 2020;34(5):2040\u20139. https:\/\/doi.org\/10.1007\/s00464-019-06984-8.","journal-title":"Surg Endosc."},{"issue":"6","key":"18022_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.10723","volume":"105","author":"G Passot","year":"2018","unstructured":"Passot G, Dumont F, Go\u00e9r\u00e9 D, et al. Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg. 2018;105(6):663\u20137. https:\/\/doi.org\/10.1002\/bjs.10723.","journal-title":"Br J Surg."},{"issue":"1","key":"18022_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1272\/jnms.67.5","volume":"67","author":"H Sugarbaker","year":"2000","unstructured":"Sugarbaker H. It\u2019s what the surgeon doesn\u2019t see that kills the patient. J Nippon Med Sch. 2000;67(1):5\u20138. https:\/\/doi.org\/10.1272\/jnms.67.5.","journal-title":"J Nippon Med Sch."},{"key":"18022_CR31","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13279-9","author":"F Schell","year":"2023","unstructured":"Schell F, Kefleyesus A, Benzerdjeb N, et al. Influence of extraperitoneal metastases on the curative-intent management of colorectal peritoneal metastases. Ann Surg Oncol. 2023. https:\/\/doi.org\/10.1245\/s10434-023-13279-9.","journal-title":"Ann Surg Oncol."},{"key":"18022_CR32","doi-asserted-by":"publisher","first-page":"111478","DOI":"10.1016\/j.ejrad.2024.111478","volume":"175","author":"CJV Rijsemus","year":"2024","unstructured":"Rijsemus CJV, Kok NFM, Aalbers AGJ, et al. Investigating locations of recurrences with MRI after CRS-HIPEC for colorectal peritoneal metastases. Eur J Radiol. 2024;175:111478. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111478.","journal-title":"Eur J Radiol."},{"issue":"1","key":"18022_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jmri.24361","volume":"40","author":"X Yu","year":"2014","unstructured":"Yu X, Lee EYP, Lai V, Chan Q. Correlation between tissue metabolism and cellularity assessed by standardized uptake value and apparent diffusion coefficient in peritoneal metastasis. Magn Reson Imaging. 2014;40(1):99\u2013105. https:\/\/doi.org\/10.1002\/jmri.24361.","journal-title":"Magn Reson Imaging."},{"issue":"3","key":"18022_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1148\/radiol.10100729","volume":"257","author":"MC Niekel","year":"2010","unstructured":"Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257(3):674\u201384. https:\/\/doi.org\/10.1148\/radiol.10100729.","journal-title":"Radiology."},{"issue":"2","key":"18022_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00261-010-9633-5","volume":"36","author":"K Holzapfel","year":"2011","unstructured":"Holzapfel K, Reiser-Erkan C, Fingerle AA, et al. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging. 2011;36(2):179\u201384. https:\/\/doi.org\/10.1007\/s00261-010-9633-5.","journal-title":"Abdom Imaging."},{"issue":"2","key":"18022_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejrad.2010.06.004","volume":"80","author":"M Bozkurt","year":"2011","unstructured":"Bozkurt M, Doganay S, Kantarci M, et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol. 2011;80(2):224\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2010.06.004.","journal-title":"Eur J Radiol."},{"issue":"13","key":"18022_CR37","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/cancers14133179","volume":"14","author":"CS Chia","year":"2022","unstructured":"Chia CS, Wong LCK, Hennedige TP, et al. Prospective comparison of the performance of MRI versus CT in the detection and evaluation of peritoneal surface malignancies. Cancers. 2022;14(13):3179. https:\/\/doi.org\/10.3390\/cancers14133179.","journal-title":"Cancers."},{"issue":"1","key":"18022_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3978\/j.issn.2078-6891.2015.115","volume":"7","author":"RN Low","year":"2016","unstructured":"Low RN. Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. J Gastrointest Oncol. 2016;7(1):58\u201371. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.115.","journal-title":"J Gastrointest Oncol."},{"issue":"4","key":"18022_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jmri.24850","volume":"42","author":"M Zaitsev","year":"2015","unstructured":"Zaitsev M, Maclaren J, Herbst M. Motion artifacts in MRI: a complex problem with many partial solutions. J Magn Reson Imaging. 2015;42(4):887\u2013901. https:\/\/doi.org\/10.1002\/jmri.24850.","journal-title":"J Magn Reson Imaging."},{"issue":"2","key":"18022_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/RLI.0000000000000914","volume":"58","author":"T Park","year":"2023","unstructured":"Park T, Kim DW, Choi SH, et al. Deep learning-based automatic detection and grading of motion-related artifacts on gadoxetic acid-enhanced liver MRI. Invest Radiol. 2023;58(2):166\u201372. https:\/\/doi.org\/10.1097\/RLI.0000000000000914.","journal-title":"Invest Radiol."},{"key":"18022_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.5179","author":"M Hewlett","year":"2024","unstructured":"Hewlett M, Petrov I, Johnson PM, Drangova M. Deep-learning-based motion correction using multichannel MRI data: a study using simulated artifacts in the fastMRI dataset. NMR Biomed. 2024. https:\/\/doi.org\/10.1002\/nbm.5179.","journal-title":"NMR Biomed."},{"key":"18022_CR42","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.ejmp.2022.12.001","volume":"105","author":"Y Wu","year":"2023","unstructured":"Wu Y, Liu J, White GM, Deng J. Image-based motion artifact reduction on liver dynamic contrast enhanced MRI. Physica Medica. 2023;105:102509. https:\/\/doi.org\/10.1016\/j.ejmp.2022.12.001.","journal-title":"Physica Medica."},{"issue":"6","key":"18022_CR43","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jso.23878","volume":"111","author":"M Torkzad","year":"2015","unstructured":"Torkzad M, Casta N, Bergman A, Ahlstr\u00f6m H, P\u00e5hlman L, Mahteme H. Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. J Surg Oncol. 2015;111(6):746\u201351. https:\/\/doi.org\/10.1002\/jso.23878.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18022-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:03Z","timestamp":1767573183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18022"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18022-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}